Biotechnology Value Fund L P's Form 4 filing
Third Harmonic Bio, Inc.THRD · filed Oct 31, 2024
- Accession no.
- 0000921895-24-002409
- Filed
- Oct 31, 2024, 5:53 PM ET
- Trade date
- Oct 29, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $14.3M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Biotechnology Value Fund L PCIK 0000918923 | Other: See Explanation of Responses |
| BVF Partners L PCIK 0001055947 | Other: See Explanation of Responses |
| BVF IncCIK 0001056807 | Other: See Explanation of Responses |
| Biotechnology Value Fund II LPCIK 0001102444 | Other: See Explanation of Responses |
| Lampert Mark NCIK 0001233840 | Other: See Explanation of Responses |
| Biotechnology Value Trading Fund OS LPCIK 0001660683 | Other: See Explanation of Responses |
| BVF Partners OS Ltd.CIK 0001660684 | Other: See Explanation of Responses |
| BVF I GP LLCCIK 0001803805 | Other: See Explanation of Responses |
| BVF II GP LLCCIK 0001803806 | Other: See Explanation of Responses |
| BVF GP Holdings LLCCIK 0001803809 | Other: See Explanation of Responses |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 29, 2024 | Common Stock | SSaleDisposed | −538,420 | $14.30 | −$7,699,406 | 1,794,218 | Direct | |
| Oct 29, 2024 | Common Stock | SSaleDisposed | −396,963 | $14.30 | −$5,676,570.9 | 1,367,257 | Direct | |
| Oct 29, 2024 | Common Stock | SSaleDisposed | −64,617 | $14.30 | −$924,023.1 | 176,692 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.